Neuro-Oncology: The Podcast

99 Folgen

1. RANO resect

   Vom: 23.6.2023
2. Methylation profiling of adult ependymoma

   Vom: 9.6.2023
3. Pseudoprogression in IDH-mutant high-grade gliomas

   Vom: 12.5.2023
4. Changes in survival outcomes in melanoma patients with brain metastases

   Vom: 21.4.2023
5. Radiation therapy and structural brain changes

   Vom: 7.4.2023
6. Objective response rate targets for recurrent glioblastoma clinical trials

   Vom: 17.3.2023
7. Mitotic count prognostic significance in IDH-mutant astrocytoma in the molecular era

   Vom: 3.3.2023
8. Palliative care in neuro-oncology

   Vom: 10.2.2023
9. Nivolumab in MGMT methylated GBM

   Vom: 27.1.2023
10. IDH mutant gliomas; SNO consensus Review

    Vom: 13.1.2023
11. DNA methylation subclass and extent of GBM resection

    Vom: 30.12.2022
12. Pre-operative [11C]methionine PET for low-grade glioma

    Vom: 16.12.2022
13. The role of T lymphocytes in the glioma pathobiology

    Vom: 2.12.2022
14. CDKN2A homozygous deletion in IDH mutant astrocytoma

    Vom: 8.10.2022
15. EGFR: the lazarus target in glioblastom

    Vom: 23.9.2022
16. Brain metastases; a SNO consensus review: Part 2

    Vom: 9.9.2022
17. Brain metastases; a SNO consensus review: Part 1

    Vom: 26.8.2022
18. Pediatric IDH mutant gliomas

    Vom: 13.8.2022
19. Low-risk meningioma: Outcomes from NRG 0539

    Vom: 29.7.2022
20. Selumetinib in children with NF1 and plexiform neurofibroma

    Vom: 1.7.2022